| 000 | 01620 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516183133.0 | ||
| 264 | 0 | _c20140930 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1421-9867 | ||
| 024 | 7 |
_a10.1159/000355529 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJuliao, Fabian | |
| 245 | 0 | 0 |
_aClinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population. _h[electronic resource] |
| 260 |
_bDigestion _c2013 |
||
| 300 |
_a222-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aColectomy |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 | _aColombia |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aIntestinal Mucosa |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 | _aWound Healing |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMarquez, Juan | |
| 700 | 1 | _aAristizabal, Natalia | |
| 700 | 1 | _aYepes, Carlos | |
| 700 | 1 | _aZuleta, Julio | |
| 700 | 1 | _aGisbert, Javier P | |
| 773 | 0 |
_tDigestion _gvol. 88 _gno. 4 _gp. 222-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000355529 _zAvailable from publisher's website |
| 999 |
_c23312769 _d23312769 |
||